These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12907256)

  • 1. Determination of meloxicam in bulk and pharmaceutical formulations.
    Zawilla NH; Abdul-Azim Mohammad M; El kousy NM; El-Moghazy Aly SM
    J Pharm Biomed Anal; 2003 Aug; 32(6):1135-44. PubMed ID: 12907256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl).
    Taha EA; Salama NN; Fattah Lel-S
    Chem Pharm Bull (Tokyo); 2006 May; 54(5):653-8. PubMed ID: 16651760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of classic and derivative UV spectrophotometric methods for quantification of meloxicam and mefenamic acid in pharmaceutical preparations.
    Pomykalski A; Hopkała H
    Acta Pol Pharm; 2011; 68(3):317-23. PubMed ID: 21648185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations.
    Vignaduzzo SE; Castellano PM; Kaufman TS
    J Pharm Biomed Anal; 2008 Jan; 46(2):219-25. PubMed ID: 17961953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new RP-HPLC method for analysis of meloxicam in tablets.
    Arayne MS; Sultana N; Siddiqui FA
    Pak J Pharm Sci; 2005 Jan; 18(1):58-62. PubMed ID: 16431386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of ultra-performance liquid chromatography method for the determination of meloxicam and its impurities in active pharmaceutical ingredients.
    Louati K; Bargaoui I; Safta F
    Ann Pharm Fr; 2018 May; 76(3):187-200. PubMed ID: 29544974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow-injection procedures.
    García MS; Sánchez-Pedreño C; Albero MI; Martí J
    Eur J Pharm Sci; 2000 Jan; 9(3):311-6. PubMed ID: 10594389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotometric and fluorimetric methods for the determination of meloxicam in dosage forms.
    Hassan EM
    J Pharm Biomed Anal; 2002 Feb; 27(5):771-7. PubMed ID: 11814718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse polarographic determination of meloxicam.
    Altiokka G; Atkosar Z; Tuncel M
    Pharmazie; 2001 Feb; 56(2):184-5. PubMed ID: 11234353
    [No Abstract]   [Full Text] [Related]  

  • 10. Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma.
    Altinöz S; Nemutlu E; Kir S
    Farmaco; 2002 Jun; 57(6):463-8. PubMed ID: 12088061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of aceclofenac in bulk and pharmaceutical formulations.
    Zawilla NH; Mohammad MA; El Kousy NM; El-Moghazy Aly SM
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):243-51. PubMed ID: 11682232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Method development and validation for the analysis of meloxicam in tablets by CZE.
    Nemutlu E; Kir S
    J Pharm Biomed Anal; 2003 Feb; 31(2):393-400. PubMed ID: 12609679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study.
    Bae JW; Kim MJ; Jang CG; Lee SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):69-73. PubMed ID: 17921074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets.
    Beltagi AM; Ghoneim MM; Radi A
    J Pharm Biomed Anal; 2002 Feb; 27(5):795-801. PubMed ID: 11814720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrochemical determination of meloxicam in pharmaceutical preparation and biological fluids using oxidized glassy carbon electrodes.
    Farhadi K; Karimpour A
    Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):638-42. PubMed ID: 17409562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Measurement of Meloxicam and Meloxicam Metabolites in Rat Plasma Using a High-Performance Liquid Chromatography-Ultraviolet Spectrophotometry Method.
    Miyamoto A; Aoyama T; Matsumoto Y
    Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):121-126. PubMed ID: 27904016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect flow-injection spectrophotometric determination of meloxicam, tenoxicam and piroxicam in pharmaceutical formulations.
    Al-Momani IF
    Anal Sci; 2006 Dec; 22(12):1611-4. PubMed ID: 17159326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of celecoxib, meloxicam, and rofecoxib using capillary electrophoresis with surfactant and application in drug formulations.
    Hsieh YH; Lin SJ; Chen SH
    J Sep Sci; 2006 May; 29(7):1009-17. PubMed ID: 16833234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC determination of rosiglitazone in bulk and pharmaceutical formulation.
    Radhakrishna T; Satyanarayana J; Satyanarayana A
    J Pharm Biomed Anal; 2002 Jul; 29(5):873-80. PubMed ID: 12093521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow-injection analysis for meloxicam based on tris(2,2'-bipyridine) ruthenium(II)-Ce(IV) chemiluminescent system.
    Ye H; Qiu B; Chen J; Lin J; Chen G
    Luminescence; 2009; 24(4):260-5. PubMed ID: 19294660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.